NASDAQ:MITO
Delisted

Stealth Biotherapeutics Stock News

etoro logo Buy MITO
*Your capital is at risk
$0.320
+0 (+0%)
At Close: Feb 14, 2023
Stealth BioTherapeutics Corp (NASDAQ:MITO) has earned a consensus rating of “Hold” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Four equities researc
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...
Stealth Bio stock more than doubled on Tuesday after the company announced a critical update from the FDA.
Foot Locker put volume heavy and directionally bearish FL
Ocular Therapeutix update gave 'positive' look at OTX-TKI , says Piper Sandler Piper Sandler OCUL
SoftBank made two billion-dollar investments in China real estate, WSJ reports SFTBY
Rite Aid call volume above normal and directionally bullish RAD
Boingo Wireless cancels out of bank conference after confirming approaches WIFI
Forty Seven downgraded to Neutral from Buy at Guggenheim Guggenheim FTSV
Fly Intel: Top five analyst initiations CTLT CRL PFHD MR SBBP
Fly Intel: Top five analyst downgrades CRON BUD SGRY UMRX CODX
Fly Intel: Top five analyst upgrades AMD TSLA UPS VAL YETI
Major averages reverse, give up gains and turn negative after Fed rate cut SPY SPX DJX NDX
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE